All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Gastrointestinal Involvement in Systemic Sclerosis : Overview, Neglected Aspects, Malnutrition, Body Composition and Management

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023728%3A_____%2F19%3AN0000027" target="_blank" >RIV/00023728:_____/19:N0000027 - isvavai.cz</a>

  • Result on the web

    <a href="https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/gastrointestinal-involvement-in-systemic-sclerosis-overview-neglected-aspects-malnutrition-body-comp" target="_blank" >https://www.intechopen.com/books/new-insights-into-systemic-sclerosis/gastrointestinal-involvement-in-systemic-sclerosis-overview-neglected-aspects-malnutrition-body-comp</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.5772/intechopen.88286" target="_blank" >10.5772/intechopen.88286</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Gastrointestinal Involvement in Systemic Sclerosis : Overview, Neglected Aspects, Malnutrition, Body Composition and Management

  • Original language description

    Gastrointestinal tract (GIT) involvement is the most common internal organ manifestation and is present in up to 90% of patients with systemic sclerosis (SSc). Clinical manifestations can differ according to the part of the GIT affected, disease course and symptoms. A majority of the symptoms are caused by GIT dysmotility. Up to 8% of SSc patients develop several GIT symptoms, which increase the mortality. Although GIT involvement is rarely the direct cause of death, it can lead to several comorbidities including malnutrition and negative alterations of body composition. These factors have a negative impact on quality of life and increase the mortality. To date, the treatment is rather symptomatic. The pathogenesis of GIT involvement in SSc still remains to be clarified to improve the treatment approaches including intravenous immunoglobulins and microRNA interventions

  • Czech name

  • Czech description

Classification

  • Type

    C - Chapter in a specialist book

  • CEP classification

  • OECD FORD branch

    30226 - Rheumatology

Result continuities

  • Project

    <a href="/en/project/NV18-01-00161" target="_blank" >NV18-01-00161: Atherosclerosis and cardiovascular risk in selected rheumatic diseases</a><br>

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Others

  • Publication year

    2019

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Book/collection name

    New Insights into Systemic Sclerosis

  • ISBN

    978-1-83962-204-5

  • Number of pages of the result

    24

  • Pages from-to

    63-86

  • Number of pages of the book

    148

  • Publisher name

    IntechOpen

  • Place of publication

    London

  • UT code for WoS chapter